Description

What is Tirzepatide?

Tirzepatide is a synthetic peptide that simultaneously activates:

• GLP-1 (Glucagon-Like Peptide-1) receptors – regulates insulin secretion and appetite

• GIP (Glucose-dependent Insulinotropic Polypeptide) receptors – enhances glucose-dependent insulin release

By targeting these pathways, Tirzepatide has shown promising results in clinical trials for:

• Weight reduction

• Blood sugar regulation

• Improved metabolic health

Key Features

• Active Substance: Tirzepatide

• Concentration: 10mg/mL

• Form: Lyophilized peptide or injectable solution

• Cycle Duration: 4 weeks (research purposes)

Research Applications

• Studying weight loss mechanisms

• Evaluating glycemic control in metabolic models

• Investigating GLP-1/GIP dual agonist activity

Usage & Storage

• For research use only

• Administer according to laboratory protocols

• Store refrigerated at 2–8°C in a dark, dry place

• Reconstitute properly before use if lyophilized

Safety Considerations

• Not intended for human consumption outside research

• Follow standard lab safety practices

• Monitor all experimental outcomes carefully